ERELZI

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: ed844e0b8ca7a09a
Drug Approval Canada Name: ERELZI
Product Name: ERELZI
Status: Marketed
Status Date: 2017-12-08
Original Market Date: 2017-12-08
Din: 02462877
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB01 ETANERCEPT
Atc Name: l 04 ab 01
Aig Number: 0151564001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

ETANERCEPT

25 MG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ed844e0b8ca7a09a

Type

Standard